HIGHLIGHTS
SUMMARY
Agnello et_al: PHI and prostate cancer organ-specific and not cancer-specific. The aim of this study was to assess the accuracy of PHI for detecting PCa and identifying csPCa. For csPCa studies (n=18), the sample size included was between 43 and 1,538, with cut-off, sensitivity and specificity ranging, respectively, from 17.8 to 67.6, from 0.533 to 1.000 and from 0.211 Agnello et_al: PHI and prostate cancer Table : Characteristics of all the studies included in the meta-analysis. Study Positive csPCa Calibrators population biopsy Hybritech Agnello . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.